The Michael J. Fox Foundation's BFDN grant supports early career researchers whose neurodegenerative disease projects were disrupted by changes in U.S. federal funding.
The Investor-Initiated Research Grants from Beyond Batten Disease Foundation fund global research to advance understanding and treatment of juvenile Batten (CLN3) disease.
Parkinson's Disease Biomarker Innovation and Advancement Program supports teams developing fluid- and imaging-based biomarkers for clinical implementation and broader use in Parkinson's research.
2027 Next Generation Research Grants support early-career researchers pursuing disease-specific and cross-condition neurological investigations to help launch academic research careers.
Accelerating Drug Discovery for Frontotemporal Degeneration supports researchers and clinicians developing small molecules and biologics to advance disease-modifying treatments for frontotemporal dementia.
Seed Grants support junior faculty pursuing innovative neuroscience pilot projects, funding new research directions that generate data for future NIH or other public and private research funding.